These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6135591)

  • 21. Tardive dyskinesia: pathophysiology and animal models.
    Casey DE
    J Clin Psychiatry; 2000; 61 Suppl 4():5-9. PubMed ID: 10739324
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blind, controlled, long-term study of the comparative incidence of treatment-emergent tardive dyskinesia with olanzapine or haloperidol.
    Tollefson GD; Beasley CM; Tamura RN; Tran PV; Potvin JH
    Am J Psychiatry; 1997 Sep; 154(9):1248-54. PubMed ID: 9286184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vitamin E treatment for tardive dyskinesia. Veterans Affairs Cooperative Study #394 Study Group.
    Adler LA; Rotrosen J; Edson R; Lavori P; Lohr J; Hitzemann R; Raisch D; Caligiuri M; Tracy K
    Arch Gen Psychiatry; 1999 Sep; 56(9):836-41. PubMed ID: 12892048
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is melatonin treatment effective for tardive dyskinesia?
    Shamir E; Barak Y; Plopsky I; Zisapel N; Elizur A; Weizman A
    J Clin Psychiatry; 2000 Aug; 61(8):556-8. PubMed ID: 10982197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beneficial effect of donepezil in the treatment of elderly patients with tardive movement disorders.
    Bergman J; Dwolatzky T; Brettholz I; Lerner V
    J Clin Psychiatry; 2005 Jan; 66(1):107-10. PubMed ID: 15669896
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clozapine treatment for neuroleptic-induced tardive dyskinesia, parkinsonism, and chronic akathisia in schizophrenic patients.
    Spivak B; Mester R; Abesgaus J; Wittenberg N; Adlersberg S; Gonen N; Weizman A
    J Clin Psychiatry; 1997 Jul; 58(7):318-22. PubMed ID: 9269253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-dose diazepam in neuroleptic-resistant schizophrenia with tardive dyskinesia.
    Eapen V; Mukherjee D; Chandra P; Sinha V; Khanna S; Channabasavanna SM
    J Clin Psychiatry; 1989 Aug; 50(8):309. PubMed ID: 2569459
    [No Abstract]   [Full Text] [Related]  

  • 28. Tardive dyskinesia presenting as gastrointestinal disorder.
    Goldberg RJ; Morris PL; Lidofsky S
    J Clin Psychiatry; 1990 Jun; 51(6):253-4. PubMed ID: 1971823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Tardive dyskinesia: pergolid, a possible therapeutic option].
    Diehl A; Braus DF; Büchel C; Krumm B; Medori R; Gattaz WF
    Psychiatr Prax; 2003 Sep; 30(6):333-7. PubMed ID: 12970819
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Utility of quetiapine in tardive dyskinesia].
    Navarro Pacheco BV; Montejo González AL; Martín Carrasco M
    Actas Esp Psiquiatr; 2003; 31(6):347-52. PubMed ID: 14639511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of gabaergic drugs on reserpine-induced oral dyskinesia.
    Peixoto MF; Araujo NP; Silva RH; Castro JP; Fukushiro DF; Faria RR; Zanier-Gomes PH; Medrano WA; Frussa-Filho R; Abílio VC
    Behav Brain Res; 2005 May; 160(1):51-9. PubMed ID: 15836900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gamma-vinyl-GABA treatment of tardive dyskinesia and other movement disorders.
    Stahl SM; Thornton JE; Simpson ML; Berger PA; Napoliello MJ
    Biol Psychiatry; 1985 Aug; 20(8):888-93. PubMed ID: 3861199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progesterone attenuates neuroleptic-induced orofacial dyskinesia via the activity of its metabolite, allopregnanolone, a positive GABA(A) modulating neurosteroid.
    Bishnoi M; Chopra K; Kulkarni SK
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):451-61. PubMed ID: 17988775
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A single-blind, randomized trial comparing quetiapine and haloperidol in the treatment of tardive dyskinesia.
    Emsley R; Turner HJ; Schronen J; Botha K; Smit R; Oosthuizen PP
    J Clin Psychiatry; 2004 May; 65(5):696-701. PubMed ID: 15163258
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuroleptic-induced tardive dyskinesia.
    Jenner P; Marsden CD
    Acta Psychiatr Belg; 1987; 87(5):566-98. PubMed ID: 2897761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of tardive dyskinesia with galantamine: a randomized controlled crossover trial.
    Caroff SN; Walker P; Campbell C; Lorry A; Petro C; Lynch K; Gallop R
    J Clin Psychiatry; 2007 Mar; 68(3):410-5. PubMed ID: 17388711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of tardive dyskinesia with lecithin.
    Jackson IV; Nuttall EA; Ibe IO; Perez-Cruet J
    Am J Psychiatry; 1979 Nov; 136(11):1458-60. PubMed ID: 40440
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Markers of glutamatergic neurotransmission and oxidative stress associated with tardive dyskinesia.
    Tsai G; Goff DC; Chang RW; Flood J; Baer L; Coyle JT
    Am J Psychiatry; 1998 Sep; 155(9):1207-13. PubMed ID: 9734544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diazepam in the treatment of tardive dyskinesia. Preliminary observations.
    Singh MM
    Int Pharmacopsychiatry; 1976; 11(4):232-4. PubMed ID: 1010710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vitamin E in the treatment of tardive dyskinesia.
    Elkashef AM; Ruskin PE; Bacher N; Barrett D
    Am J Psychiatry; 1990 Apr; 147(4):505-6. PubMed ID: 1969247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.